Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,997 total articles
Latham Group (SWIM) has been under pressure this spring but recent operational wins, an accretive Australia acquisition, and elevated short interest set the stock up for a tradable rebound. This is a swing trade: buy at $5.90, stop at $5.10, target $7.25 over the next 45 trading days.
Dow is a structurally advantaged chemical producer as U.S. gas stays well below European prices. The gap supports stronger margins for ethylene-integrated players, export competitiveness, and a pathway to rebuild EBITDA despite recent supply-chain headwinds. Trade idea: enter long at current levels, protect with a tight stop and target the next res…
<p>Alphamin sits squarely in the sweet spot of a tightening tin market: concentrated supply, a scarce high-grade asset and rising realization that tin is critical to electronics and electrification supply chains. That macro backdrop is finally converting into visible cash flow. For traders willing to accept jurisdictional and operational risk, Alph…
GLSI is a small-cap biotech with Phase III FLAMINGO-01 results that look better than most investors expect. Recent abstracts and patent claims expand the possible market; Nasdaq filing delays and a tight cash runway keep risk elevated. This trade targets a mid-term re-rating into $30 if upcoming filings and conference exposure confirm the early eff…
AIB Data Centers (AIB) is a microcap with $127M market cap that recently raised roughly $63.25M in gross proceeds. The stock trades near $1.675 after a steep drawdown from a $6.28 52-week high. If management lands a material AI hosting lease or announces new HPC capacity tied to AI customers, revenue and multiple expansion could follow quickly. Thi…
IES Holdings (IESC) remains a high-quality industrial services platform with strong margins, a healthy backlog and near-zero leverage. But recent M&A and capacity builds (Gulf Island integration, fabrication facility add-ons) imply the investment-to-return timeline is longer than the market has priced. For traders: consider a mid-term short/swing p…
ERock is trading well below its IPO price despite a $1.3B order backlog and plans to expand manufacturing to 1.2 GW by end of 2026. The market has punished the name while it scales production and runs at a loss. If management can convert backlog into shipments and tighten margins, the valuation at $2.64B market cap looks recoverable. This trade buy…
IBM has finally given the market a clean reset after recent weakness. This trade idea lays out a measured, mid-term swing trade using defined entry, stop and target levels while arguing why IBM's services and software franchise can reprice higher over the next 45 trading days if catalysts line up.
Global X MLP ETF (MLPA) is a sensible, income-focused way to own a basket of U.S. midstream MLPs. The fund yields north of 6% with a 30-day SEC yield near 7.4%, trades near its 10- and 50-day averages, and carries reasonable liquidity. It is appealing for yield-seeking investors, but structural tax treatment, limited capital appreciation potential,…
Telesat (TSAT) can punch above its weight if management executes an asset-light strategy and secures government/commercial anchor contracts. SpaceX's Starlink remains the dominant force, but Telesat's differentiated GEO/MEO capabilities and partner-driven model create a possible asymmetric upside. I recommend a long with precise entry, target, and …
Direxion Daily Small Cap Bull 3x Shares (TNA) offers a high-risk, high-reward way to play a potential small-cap rebound. Technicals show weakening momentum in the near term, but structural catalysts - including potential Fed easing and historically strong small-cap seasonality - support a rebound over the next several months. Trade plan: enter at $…
EverQuote (EVER) is profitable, cash-generative and trading at a low P/E, but the stock appears to reflect a hard normalization in lead pricing and growth. With technicals stretched and short interest elevated, a disciplined short-swing targeting a return to structural support offers asymmetric risk-reward — provided you respect a clearly defined s…
Harmonic is transitioning from hardware-led video processing to software-first broadband access (cOS) and cloud-native streaming (VOS 360). With a $1.41B market cap, positive free cash flow and a product roadmap aligned to the DOCSIS 4.0 upgrade cycle, HLIT looks like a buyable long on a confirmed recovery in operator capex. This trade lays out an …
Norwood Financial (NWFL) has quietly built a stronger regional bank after the Presence Bank deal and technology investments. The balance sheet metrics, improving margins and a reliable $0.32 quarterly dividend support a mid-term long trade. Entry at current levels offers a favorable risk-reward if management executes on integration and margin tailw…
Verizon's core wireless and wireline cash flows remain intact even as satellite entrants stir investor anxiety. At roughly $42.62, the stock offers an attractive FCF yield and a safe-looking dividend backed by $20.3B of free cash flow and a reasonable EV/EBITDA. This trade idea lays out an entry, stop and $50 target across a position-term horizon a…
Compass Therapeutics (CMPX) trades near $2.15 with a $388M market cap after a disappointing overall survival result for tovecimig and an abrupt share-price reset. The market appears to have over-rotated, discounting the company’s other assets and a $120M capital raise that extends runway. We outline a swing trade with entry at $2.15, a stop at $1.6…
Celcuity just received FDA approval for REVTORPYK (gedatolisib) in HR+/HER2- PIK3CA wild-type advanced breast cancer and is moving to a late Q3 2026 commercial launch. The stock has already run; today's pullback creates a tactical entry to own the commercial rollout, upcoming sNDA ambitions, and potential multiple expansion if uptake proves durable…
Taiwan Fund, Inc. (TWN) offers a uniquely leveraged way to own Taiwan-listed equities, trading at value multiples (P/E ~2.36, P/B ~1.16) while paying a 6.8% distribution. With Taiwan central to global AI hardware supply chains, TWN is a tactical long for investors willing to ride country and sector volatility toward a recovery to prior highs ($105.…
Sigma Lithium (SGML) has slipped under many investors' radar after a volatile run of operational setbacks and legal headlines. The company shows signs of stabilization: restarted sales, binding offtakes with prepayments, falling short interest and a sub‑$1.3B market cap that still prices optionality around future production growth. For traders will…
M&T Bank (MTB) trades near a 52-week high on improving fundamentals: mid-teens P/E relative to visible earnings power, a $1.50 quarterly dividend, and strong free cash flow. This trade proposes a disciplined long-term buy at $245.00 with a $236.00 stop and a $280.00 target over 180 trading days.
AstraZeneca (AZN) fell after the Phase-3 CARDIO-TTRansform failure for Wainua; the selloff looks larger than the program's economic impact. Strong oncology cash flows, an $80B 2030 revenue target still intact, and upcoming pipeline readouts make a structured long the highest-probability trade here. Entry $168.91, stop $155.00, target $195.00 on a l…
TECL plunged alongside a risk-off move but macro cues - specifically softer inflation readings and fading Fed hawkishness - set the stage for a rebound in high-beta tech exposure. This trade idea outlines an actionable mid-term long (45 trading days) with clear entry, stop and target while spelling out the unique risks of a 3x leveraged ETF.
S&P Global rallied after spinning off Mobility Global, yet some bears point to AI as an existential threat to data and analytics businesses. That thesis is overstated. With a $132.2B market cap, $5.56B in free cash flow, and entrenched, mission-critical franchises, S&P Global looks set to out-earn the headlines. This trade idea outlines an entry at…
Nebius Group (NBIS) fell after Meta cloud headlines but fundamentals and supply constraints in AI compute favor independent neoclouds. Valuation at a $48.7B market cap and 57x earnings prices growth, yet the stock sits ~35% below its 52-week high and shows oversold technicals that support a long-term trade. Entry $195, stop $175, target $280 over 1…
Klarna's strategy of using targeted acquisitions to fill product gaps and accelerate merchant distribution is translating to better unit economics and cross-sell opportunities. We view the current price as a buying opportunity for a long trade that captures continued integration upside and multiple expansion, while limiting downside with a strict s…
